Log In
Print
BCIQ
Print
Print this Print this
 

MDDScore

  Manage Alerts
Collapse Summary General Information
Company Ridge Diagnostics Inc.
DescriptionBlood-based test that utilizes immunoassay technology and biomarker hypermapping (BHyperMap) and measures 10 biomarker levels to determine if a patient has major depressive disoder (MDD)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationNeurology, Diagnostic
Indication DetailsDiagnose major depressive disorder (MDD)
Regulatory Designation

Partner

Ameritox Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today